sibenadet has been researched along with venlafaxine in 1 studies
| Studies (sibenadet) | Trials (sibenadet) | Recent Studies (post-2010) (sibenadet) | Studies (venlafaxine) | Trials (venlafaxine) | Recent Studies (post-2010) (venlafaxine) |
|---|---|---|---|---|---|
| 27 | 7 | 6 | 69 | 0 | 36 |
| Protein | Taxonomy | sibenadet (IC50) | venlafaxine (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.708 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.1114 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0625 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.3955 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.33 | |
| Transporter | Rattus norvegicus (Norway rat) | 0.64 | |
| Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.027 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
1 other study(ies) available for sibenadet and venlafaxine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |